// App-Quantinova.ai

: Clinical Utility of Machine Learning-Derived Vocal-Biomarker in the Management of Heart Failure

Researchers

Presenter

  • Kozo Okada

Principal Investigators

  • Yasuhiro Omiya

  • Daisuke Mizuguchi

  • Koji Endo

  • Yusuke Kobayashi

  • yasushi matsuzawa

  • Noriaki Iwahashi

  • Masami Kosuge

  • Toshiaki Ebina

  • Kouichi Tamura

  • Kiyoshi Hibi

Medical Centers

  • YOKOHAMA CITY UNIV HOSPITAL, Yokohama, Japan

  • YOKOHAMA CITY UNIV MED CTR, Yokohama, Japan

  • YOKOHAMA CITY UNIV MED CTR, Yokohama, Japan

  • YOKOHAMA CITY UNIV MED CTR, Yokohama, Japan

  • YOKOHAMA CITY UNIV MED CTR, Yokohama, Japan

  • Yokohama City University, Yokohama, Japan

  • YOKOHAMA CITY UNIVERSITY MED CENTER, Yokohama

  • PST Inc., Yokohama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

Biomarkers

  • B-type natriuretic peptide

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Single Center

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved